SentiBio
not logic gate functions in to specifically kill cancer cells and spare healthy cells a sie | SentiBio
Company
Deck Type
Deck date
October 2021
Slide
11 of 52
Related slides by other companies
Genprex
Investor Presentation
October 2022
in small cell lung cancer | Genprex
Absci
Investor Presentation
July 2023
antibodies selected in tertiary lymphoid structures bind to cancer cells and are associated with favorable clinical outcomes | Absci
BioAtla
Investor Presentation
May 2023
selective and targeted cab technology widens therapeutic window | BioAtla
BioAtla
Investor Presentation
August 2022
selective and targeted cab technology widens therapeutic window | BioAtla
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights